Table 1.
Patient baseline characteristics.
| Total N = 16 | |
|---|---|
| Women,n (%) | 9 (56) |
| Age (y), median (Q1-Q3) | 62 (46-73) |
| Caucasian ethnicity,n (%) | 15 (94) |
| Active neoplasm,n (%) | 6 (38) |
| Plasma cell neoplasm | 3 (19) |
| Melanoma | 1 (6) |
| Acute myeloid leukemia | 1 (6) |
| Prostate carcinoma | 1 (6) |
| Thrombophilia, n (%) | 2 (13) |
| Factor V G1691A | 1 (6) |
| Protein C or S deficiency | 1 (6) |
| Antiphospholipid syndrome | 0 (0) |
| Prothrombin G20210A | 0 (0) |
| Antithrombin deficiency | 0 (0) |
| Diabetes mellitus, n (%) | 2 (13) |
| Arterial hypertension, n (%) | 4 (25) |
| Chronic heart failure, n (%) | 2 (13) |
| Coronary artery disease, n (%) | 2 (13) |
| Previous pulmonary embolism, n (%) | 1 (6) |
| Previous DVT, n (%) | 4 (25) |
| Previous PVT, n (%) | 1 (6) |
| Venous malformation, n (%) | 1 (6) |
| Surgery in last 3 months, n (%) | 2 (13) |
| Immobilization, n (%) | 2 (13) |
| Autoimmune disease, n (%) | 2 (13) |
| Smoking, n (%) | 1 (6) |
DVT, deep vein thrombosis; PVT, plantar vein thrombosis.